REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,064,143 | -50.6% | 1,230,641 | -52.2% | 22.62% | -15.5% |
| Q2 2023 | $68,940,635 | -30.5% | 2,577,220 | -43.7% | 26.76% | -25.4% |
| Q1 2023 | $99,156,014 | -9.1% | 4,577,840 | 0.0% | 35.85% | -1.2% |
| Q4 2022 | $109,044,149 | +20.8% | 4,577,840 | 0.0% | 36.30% | +81.7% |
| Q3 2022 | $90,275,000 | +5.4% | 4,577,840 | +4.2% | 19.98% | +9.6% |
| Q2 2022 | $85,660,000 | +0.3% | 4,395,050 | +31.3% | 18.23% | +15.2% |
| Q1 2022 | $85,388,000 | +1.4% | 3,347,245 | 0.0% | 15.83% | +38.2% |
| Q4 2021 | $84,250,000 | -8.5% | 3,347,245 | 0.0% | 11.46% | +9.4% |
| Q3 2021 | $92,083,000 | -13.3% | 3,347,245 | 0.0% | 10.48% | -30.3% |
| Q2 2021 | $106,242,000 | -35.3% | 3,347,245 | -6.5% | 15.04% | -4.4% |
| Q1 2021 | $164,262,000 | +15.9% | 3,580,252 | 0.0% | 15.74% | +22.4% |
| Q4 2020 | $141,742,000 | – | 3,580,252 | – | 12.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |